Atlas Arteria Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Atlas Arteria ha aumentado sus beneficios a una tasa media anual de 53.2%, mientras que los beneficios de la industria de Infrastructure han experimentado un crecimiento de 4.1% anual. Los ingresos han ido disminuyendo a una tasa media de 4.6% al año. La rentabilidad financiera de Atlas Arteria es de 4.1%, y sus márgenes netos son de 241.4%.

Información clave

53.2%

Tasa de crecimiento de los beneficios

44.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Infrastructure	-0.7%
Tasa de crecimiento de los ingresos	-4.6%
Rentabilidad financiera	4.1%
Margen neto	241.4%
Próxima actualización de resultados	29 Aug 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Apr 07

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Dec 22

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Aug 10

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

May 31

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Apr 14

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Mar 03

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Feb 27

Atlas Arteria (ASX:ALX) Has Compensated Shareholders With A Respectable 78% Return On Their Investment

Jan 31

Atlas Arteria Limited (ASX:ALX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Dec 27

How Many Atlas Arteria Limited (ASX:ALX) Shares Do Institutions Own?

Dec 06

Is There Now An Opportunity In Atlas Arteria Limited (ASX:ALX)?

Nov 19

Atlas Arteria (ASX:ALX) Has Gifted Shareholders With A Fantastic 142% Total Return On Their Investment

Jul 30

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Atlas Arteria. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

ASX:ALX Ingresos, gastos y beneficios (AUD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	134	324	8
30 Sep 23	131	315	8
30 Jun 23	150	307	10
31 Mar 23	145	287	10
31 Dec 22	118	267	7
30 Sep 22	115	264	7
30 Jun 22	111	260	7
31 Mar 22	106	222	6
31 Dec 21	101	183	5
30 Sep 21	96	134	4
30 Jun 21	91	85	3
31 Mar 21	99	13	5
31 Dec 20	107	-60	8
30 Sep 20	128	-37	13
30 Jun 20	149	-14	18
31 Mar 20	162	2	26
31 Dec 19	175	17	34
30 Sep 19	167	17	40
30 Jun 19	159	18	46
31 Mar 19	146	47	82
31 Dec 18	132	77	119
30 Sep 18	126	78	118
30 Jun 18	120	78	116
31 Mar 18	101	270	82
31 Dec 17	83	462	48
30 Sep 17	54	506	13
30 Jun 17	25	550	-22
31 Mar 17	14	388	40
31 Dec 16	3	225	101
30 Sep 16	2	162	134
30 Jun 16	2	99	167
31 Mar 16	2	92	98
31 Dec 15	2	85	29
30 Sep 15	3	71	27
30 Jun 15	3	58	25
31 Mar 15	2	4	54
31 Dec 14	2	-51	83
30 Jun 14	2	-47	83
31 Mar 14	1	-3	53
31 Dec 13	1	42	22
30 Jun 13	0	5	18

Ingresos de calidad: ALX tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio de ALX son superiores a los del año pasado .

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lALX han crecido significativamente en un 53.2% al año.

Acelerando crecimiento: El crecimiento de los beneficios de ALX en el último año (21.2%) está por debajo de su media de 5 años (53.2% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de ALX en el último año (21.2%) superó al de la industria Infrastructure 7.2%.

Rentabilidad financiera

Alta ROE: La rentabilidad financiera de ALX (4.1%) se considera baja.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Atlas Arteria Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)

First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)

Atlas Arteria Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)

Atlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023

First half 2022 earnings released: EPS: AU$0 (vs AU$0.074 in 1H 2021)

Recent updates

Final dividend of AU$0.20 announced

Atlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024

Atlas Arteria Limited, Annual General Meeting, May 15, 2024

Atlas Arteria Limited, Annual General Meeting, May 16, 2024

Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)

Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Consensus EPS estimates fall by 11%

First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)

Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023

Atlas Arteria Limited to Report First Half, 2024 Results on Aug 29, 2024

Atlas Arteria Limited Appoints Ken Daley as Director

Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023

Consensus EPS estimates fall by 15%

Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)

Insufficient new directors

Atlas Arteria Limited Announces Board Changes

Atlas Arteria Limited (ASX:ALX) completed the acquisition of 66.67% stake in Skyway Concession Company, LLC from CPP Investments and OMERS Infrastructure.

Now 20% undervalued after recent price drop

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2023

Consensus revenue estimates increase by 10%

Atlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023

Price target decreased to AU$6.96

Investor sentiment deteriorated over the past week

Atlas Arteria Limited Provides Distribution Guidance for the Year 2023

Atlas Arteria Limited (ASX:ALX) entered into an agreement to acquire a 66.67% stake in Skyway Concession Company, LLC for $2 billion.

Consensus EPS estimates fall by 14%

First half 2022 earnings released: EPS: AU$0 (vs AU$0.074 in 1H 2021)

Atlas Arteria Limited Provides Dividend Guidance for the First Half of 2022

Price target increased to AU$7.40

Investor sentiment improved over the past week

Atlas Arteria Limited Announces Executive Changes

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Independent Non-Executive Director recently bought AU$76k worth of stock

Full year 2021 earnings: EPS and revenues miss analyst expectations

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Insider recently bought AU$67k worth of stock

First half 2021 earnings released: EPS AU$0.074 (vs AU$0.14 loss in 1H 2020)

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

Price target decreased to AU$6.21

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Independent Chairman of the Board recently bought AU$100k worth of stock

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Full year 2020 earnings released: AU$0.061 loss per share (vs AU$0.024 profit in FY 2019)

Atlas Arteria Limited Announces Board Changes

New 90-day low: AU$5.97

Atlas Arteria Limited to Report Fiscal Year 2020 Results on Feb 25, 2021

Atlas Arteria (ASX:ALX) Has Compensated Shareholders With A Respectable 78% Return On Their Investment

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2021

Atlas Arteria Limited (ASX:ALX) Shares Could Be 44% Below Their Intrinsic Value Estimate

How Many Atlas Arteria Limited (ASX:ALX) Shares Do Institutions Own?

Is There Now An Opportunity In Atlas Arteria Limited (ASX:ALX)?

Atlas Arteria Limited Announces Changes to its Board

New 90-day low: AU$5.95

New 90-day low: AU$6.07

New 90-day low - AU$6.10

Atlas Arteria Limited (ASX:ALX) acquired 6.14% stake in APRR and ADALEC from Macquarie European Infrastructure Fund II managed by Macquarie Infrastructure and Real Assets (Europe) Limited.

Earnings released

Atlas Arteria (ASX:ALX) Has Gifted Shareholders With A Fantastic 142% Total Return On Their Investment

Atlas Arteria Limited has completed a Follow-on Equity Offering in the amount of AUD 74.999999 million.

Desglose de ingresos y gastosBeta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Desglose de ingresos y gastos
Beta